Philip Richter's representation of Goldman Sachs, financial advisor to Bristol-Myers, in connection with the sale of Bristol-Myers' stake in a diabetes-focused joint venture reported by <em>New York Law Journal</em>

Philip Richter's representation of Goldman Sachs, financial advisor to Bristol-Myers, in connection with the sale of Bristol-Myers' stake in a diabetes-focused joint venture reported by New York Law Journal

Corporate partner Philip Richter's representation of Goldman Sachs, financial advisor to Bristol-Myers Squibb Company, in connection with the sale of Bristol-Myers' stake in a diabetes-focused joint venture to AstraZeneca was reported by New York Law Journal.

news-detail.inc